Biogen (BIIB) Depreciation and Depletion (2018 - 2026)

Biogen's Depreciation and Depletion history runs 9 years deep, the most recent figure standing at $67.9 million for Q1 2026.

• In Q1 2026, Depreciation and Depletion fell 4.9% year-over-year to $67.9 million; the TTM figure through Mar 2026 stood at $269.3 million (down 6.75% YoY), while the FY2025 annual figure was $272.8 million, down 4.85% from the prior year.
• Depreciation and Depletion was $67.9 million for Q1 2026 at Biogen, roughly flat from $68.0 million in the prior quarter.
• In the past five years, Depreciation and Depletion ranged from a high of $76.3 million in Q1 2022 to a low of $62.1 million in Q1 2023.
• Historically, Depreciation and Depletion has averaged $67.9 million across 5 years, with a median of $67.2 million in 2022.
• The sharpest annual moves came in 2022 and 2023: Depreciation and Depletion surged 56.35% in 2022, then declined 18.61% in 2023.
• A 5-year view of Depreciation and Depletion shows it stood at $64.7 million in 2022, then retreated by 1.85% to $63.5 million in 2023, then gained by 14.65% to $72.8 million in 2024, then dropped by 6.59% to $68.0 million in 2025, then retreated by 0.15% to $67.9 million in 2026.
• The last three Depreciation and Depletion figures came in at $67.9 million (Q1 2026), $68.0 million (Q4 2025), and $66.5 million (Q3 2025), per Business Quant data.